478 related articles for article (PubMed ID: 2755078)
21. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
[TBL] [Abstract][Full Text] [Related]
22. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes.
Edge AS; Spiro RG
Diabetologia; 2000 Aug; 43(8):1056-9. PubMed ID: 10990084
[TBL] [Abstract][Full Text] [Related]
23. [Altered glomerular mRNA expression of basement membrane components and type I collagen in diabetic rats treated with or without insulin therapy].
Fukui M
Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):275-81. PubMed ID: 2062013
[TBL] [Abstract][Full Text] [Related]
24. [Immunohistochemical localization of various components of the basal membrane and interstitial collagen in diabetic nephropathy].
Nerlich A; Schleicher E
Verh Dtsch Ges Pathol; 1989; 73():133-8. PubMed ID: 2482599
[TBL] [Abstract][Full Text] [Related]
25. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor.
Vigny M; Ollier-Hartmann MP; Lavigne M; Fayein N; Jeanny JC; Laurent M; Courtois Y
J Cell Physiol; 1988 Nov; 137(2):321-8. PubMed ID: 2973466
[TBL] [Abstract][Full Text] [Related]
26. Decreased anionic sites in Bruch's membrane of spontaneous and drug-induced diabetes.
Caldwell RB; Slapnick SM; McLaughlin BJ
Invest Ophthalmol Vis Sci; 1986 Dec; 27(12):1691-7. PubMed ID: 2432030
[TBL] [Abstract][Full Text] [Related]
27. Early increase of chondroitin sulfate glycosaminoglycan in the glomerular basement membrane of rats with diabetic glomerulopathy.
Karasawa R; Nishi S; Suzuki Y; Imai N; Arakawa M
Nephron; 1997; 76(1):62-71. PubMed ID: 9171302
[TBL] [Abstract][Full Text] [Related]
28. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
Cohen MP; Klepser H; Wu VY
Diabetes; 1988 Oct; 37(10):1324-7. PubMed ID: 2970980
[TBL] [Abstract][Full Text] [Related]
29. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
Gambaro G; Venturini AP; Noonan DM; Fries W; Re G; Garbisa S; Milanesi C; Pesarini A; Borsatti A; Marchi E
Kidney Int; 1994 Sep; 46(3):797-806. PubMed ID: 7527876
[TBL] [Abstract][Full Text] [Related]
30. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate?
van den Born J; Berden JH
Nephrol Dial Transplant; 1995; 10(8):1277-9. PubMed ID: 8538909
[No Abstract] [Full Text] [Related]
31. [The relation between the changes of width and anionic sites of glomerular basement membrane and transferrinuria in rats].
Chen Y; Qian Y
Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):537-9, 574. PubMed ID: 8556544
[TBL] [Abstract][Full Text] [Related]
32. Differences in the solubility and susceptibility to proteolytic degradation of basement-membrane components in adult and embryonic mouse tissues.
Dziadek M; Mitrangas K
Am J Anat; 1989 Apr; 184(4):298-310. PubMed ID: 2526998
[TBL] [Abstract][Full Text] [Related]
33. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
[TBL] [Abstract][Full Text] [Related]
34. Heparan sulfate proteoglycan is present in basement membrane as a double-tracked structure.
Inoue S; Grant D; Leblond CP
J Histochem Cytochem; 1989 May; 37(5):597-602. PubMed ID: 2522961
[TBL] [Abstract][Full Text] [Related]
35. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.
Tamsma JT; van den Born J; Bruijn JA; Assmann KJ; Weening JJ; Berden JH; Wieslander J; Schrama E; Hermans J; Veerkamp JH
Diabetologia; 1994 Mar; 37(3):313-20. PubMed ID: 8174847
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone increases heparan sulfate proteoglycan core protein content of glomerular epithelial cells.
Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
J Lab Clin Med; 1990 Feb; 115(2):196-202. PubMed ID: 2137158
[TBL] [Abstract][Full Text] [Related]
37. In vivo turnover of the basement membrane and other heparan sulfate proteoglycans of rat glomerulus.
Beavan LA; Davies M; Couchman JR; Williams MA; Mason RM
Arch Biochem Biophys; 1989 Mar; 269(2):576-85. PubMed ID: 2521995
[TBL] [Abstract][Full Text] [Related]
38. Alterations of glomerular basement membrane charge and structure in diabetic nephropathy.
Goode NP; Shires M; Crellin DM; Aparicio SR; Davison AM
Diabetologia; 1995 Dec; 38(12):1455-65. PubMed ID: 8786020
[TBL] [Abstract][Full Text] [Related]
39. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome.
Vernier RL; Klein DJ; Sisson SP; Mahan JD; Oegema TR; Brown DM
N Engl J Med; 1983 Oct; 309(17):1001-9. PubMed ID: 6225948
[TBL] [Abstract][Full Text] [Related]
40. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
